MedTrace Logo

Transfusion Strategies in Pediatric Cardiothoracic Surgery

NCT00350220 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the best red blood cell(hemoglobin) level for infants and children following surgical repair of particular heart defects. These children often receive red blood cell transfusions after surgery, but what the best hemoglobin level is for them remains unknown.

Conditions

  • Congenital Heart Disease

Interventions

OTHER

transfusion strategy

For the High Hb group; transfusions will be given to keep the Hb \>13.0 g/dl

OTHER

Low Hb transfusion group

RBCs will not be transfused unless the Hb \< 9.0 g/dl

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Jill M Cholette, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Months
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350220 on ClinicalTrials.gov